Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-07-30 to 2024-07-31
Current total value of award: $67.8
Description: 4565293777!NEOMYCIN-POLYMYXIN-HC EAR SUSP